|
Secondary prevention
Citations 1-10 of 172 total displayed.
|
Most recent content
(1 May 2008):
|
- Emerging Therapies
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke: A Critical Review
- Martin J. O’Donnell, Graeme J. Hankey, and John W. Eikelboom
Stroke 39: 1638 -1646; published online before print as doi:10.1161/STROKEAHA.107.497271
[Abstract]
[Full text]
|
Past content
(since Jun 2001):
|
- Articles
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS). A Randomized, Double-Blind, Aspirin-Controlled Trial
- Yukito Shinohara, Katsuya Nishimaru, Tohru Sawada, Akiro Terashi, Shunnosuke Handa, Shunsaku Hirai, Kunihiko Hayashi, Hideo Tohgi, Yasuo Fukuuchi, Shinichiro Uchiyama, Takenori Yamaguchi, Shotai Kobayashi, Kazuoki Kondo, Eiichi Otomo, Fumio Gotoh for the S-ACCESS Study Group
Stroke published April 3, 2008, doi:10.1161/STROKEAHA.107.505131
[Abstract]
- Articles
Outpatient Practice Patterns After Stroke Hospitalization Among Neurologists
- Bruce Ovbiagele, Oksana Drogan, Walter J. Koroshetz, Pierre Fayad, and Jeffrey L. Saver
Stroke published April 3, 2008, doi:10.1161/STROKEAHA.107.504860
[Abstract]
- Articles
Importance of In-Hospital Initiation of Therapies and Therapeutic Inertia in Secondary Stroke Prevention. IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study
- Emmanuel Touzé, Joël Coste, Magdalena Voicu, Jamal Kansao, Rafik Masmoudi, Benoît Doumenc, Pierre Durieux, and Jean-Louis Mas
Stroke published April 3, 2008, doi:10.1161/STROKEAHA.107.503094
[Abstract]
- Original Contributions
Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack
- Nancy K. Hills and S. Claiborne Johnston
Stroke 39: 1228 -1232; published online before print as doi:10.1161/STROKEAHA.107.496729
[Abstract]
[Full text]
- Original Contributions
Xenon and Hypothermia Combine Additively, Offering Long-Term Functional and Histopathologic Neuroprotection After Neonatal Hypoxia/Ischemia
- Catherine Hobbs, Marianne Thoresen, Alexander Tucker, Kristian Aquilina, Ela Chakkarapani, and John Dingley
Stroke 39: 1307 -1313; published online before print as doi:10.1161/STROKEAHA.107.499822
[Abstract]
[Full text]
- Comments, Opinions, and Reviews
Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA: A Meta-Analysis
- Piero Verro, Phillip B. Gorelick, and Danh Nguyen
Stroke 39: 1358 -1363; published online before print as doi:10.1161/STROKEAHA.107.496281
[Abstract]
[Full text]
- Cochrane Corner
Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update
- Els L.L.M. De Schryver, Ale Algra, and Jan van Gijn
Stroke 39: 1397 -1398; published online before print as doi:10.1161/STROKEAHA.107.499723
[Full text]
- Articles
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke. A Critical Review
- Martin J. O'Donnell, Graeme J. Hankey, and John W. Eikelboom
Stroke published March 27, 2008, doi:10.1161/STROKEAHA.107.497271
[Abstract]
- Articles
Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack
- Nancy K. Hills and S. Claiborne Johnston
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.496729
[Abstract]
|
|
